Common Contracts
5 similar Clinical Trial Agreement contracts
Clinical Trial Agreement smlouva o klinickém hodnoceníClinical Trial Agreement • November 1st, 2017
The Clinical Trial Agreement (“Agreement”) is made by and between: Tato smlouva o klinickém hodnocení (“Smlouva”) je uzavírána mezi následujícími stranami:
ContractClinical Trial Agreement • June 15th, 2017
Clinical Trial Agreement The Clinical Trial Agreement (“Agreement”) is made by and between: Ústav pro péči o matku a dítě, having a place of business at Podolské nábřeží 157/36, 147 00 Praha 4 - Podolí, Czech Republic, Identification number: 00023698, Tax identification number: CZ00023698, represented by assoc.prof. Jaroslav Feyereisl, MD, CSc., director (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ247 68 651, (“Quintiles”), and Chiesi Farmaceutici S.p.A., having a place of business at Via Palermo 26/A 43122 Parma – Italy, Codice Fiscale e Partita IVA IT 01513360345, Registro d delle Impresse di Parma N. 15739, upon power of attorney represented by Quintiles Czech Republic, s.r.o (“Sponsor”) Each a “Party” and together the “Parties”. Protocol Number: CCD-01534CA1-01 Protocol Title: A ran
CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍClinical Trial Agreement • May 31st, 2017
Uherskohradišťská nemocnice a.s., having a place of business at J. E. Purkyně 365, 686 68 Uherské Hradiště, Identification number: 27660915, Tax identification number: CZ27660915, represented by MUDr. Petr Sládek, Chairman of Board (the “Institution”), and
Clinical Trial Agreement smlouva o klinickém hodnoceníClinical Trial Agreement • April 26th, 2017
The Clinical Trial Agreement (“Agreement”) is made by and between: Tato smlouva o klinickém hodnocení (“Smlouva”) je uzavírána mezi následujícími stranami:
ContractClinical Trial Agreement • September 7th, 2016
CLINICAL TRIAL AGREEMENT The Clinical Trial Agreement (“Agreement”) is made by and between: Nemocnice na Bulovce, having a place of business at Budínova 67/2, Praha 8, ZIP code 180 81, Czech Republic, Identification number: 00064211, Tax identification number: CZ00064211, represented by MUDr. Tomáš Podlešák, Deputy for Medical and Preventive Care, based on its authorisation (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ24768 651 (“Quintiles”), and TopiVert Pharma Limited, having a place of business at Imperial College Incubator Bessemer Building Level 1, Imperial College London, London SW 2AZ, United Kingdom of Great Britain and Northern Ireland, Identification number: 7757916, Tax identification number: GB7757916, (“Sponsor”) Each a “Party” and together the “Parties”. SMLOUVA O KLINICKÉM HODNOCENÍ
